Individualizing Surveillance Mammography for Older Breast Cancer Survivors
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Breast Cancer
- Sponsor
- Dana-Farber Cancer Institute
- Enrollment
- 45
- Locations
- 1
- Primary Endpoint
- Rate of Change in Intentions for Mammography in the Next Year
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
This research is being conducted to develop consensus on surveillance mammography and follow-up for breast cancer survivors who are age ≥75.
Detailed Description
The investigators will develop a communication tool that summarizes recommendations for clinicians and patients for surveillance mammography and follow-up care for breast cancer survivors age ≥75. Developing expert-panel recommendations, examining clinician and patient attitudes towards these recommendations, and testing a strategy for communication of expert recommendations on mammography cessation through direct engagement of specialists, primary care clinicians (PCs), and patients. This is a multi-step study, the investigators will build on prior steps to develop consensus on surveillance mammography and follow-ups for breast cancer survivors who are age \>= 75. This study includes a physician focus group.
Investigators
Rachel Freedman, MD, MPH
Principal Investigator
Dana-Farber Cancer Institute
Eligibility Criteria
Inclusion Criteria
- •Female gender, given that screening guidelines do not exist for men
- •Receiving part or all of their care at DFCI
- •Ages 75-79 (approximately 15 patients)
- •Age ≥80 (approximately 15 patients)
- •History of stage 0-II breast cancer
- •≥1 Charlson comorbidity present72, defined as one of the following:
- •Liver disease
- •History of or other active malignancy other than non-melanoma skin cancers
- •HIV or AIDS
- •Chronic kidney disease
Exclusion Criteria
- •Are unable to consent
- •Who do not read and write English (for this initial pilot)
Outcomes
Primary Outcomes
Rate of Change in Intentions for Mammography in the Next Year
Time Frame: 2 years
Survey measure on whether mammography will be done or not
Secondary Outcomes
- Rate of Satisfaction(2 years)
- Preferred Decision-making Role(2 years)